Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast crossover study in age-related memory impairment
NL-OMON40236Active, not recruiting
- Sponsor
- Takeda
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of roflumilast in dysmnesia and Mild Cognitive Impairment (MCI) (4 arms), sponsored by Takeda. Primary endpoint: Verbal Learning Test recall and recognition outcomes. Started Nov 2013; status: active, not recruiting.
02
Drugs
roflumilast
03
Conditions
dysmnesiaMild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NL-OMON40236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40236.